Non-alcoholic fatty liver disease and lipotoxicity

被引:31
作者
Wasilewska, Natalia [1 ]
Lebensztejn, Dariusz Marek [1 ]
机构
[1] Med Univ Bialystok, Dept Pediat Gastroenterol Hepatol Nutr & Allergol, 17 Waszyngtona St, PL-15274 Bialystok, Poland
关键词
non-alcoholic fatty liver disease; lipotoxicity; non-alcoholic steatohepatitis; CIRCULATING OXIDIZED-LDL; METABOLIC SYNDROME; INSULIN-RESISTANCE; CARDIOVASCULAR-DISEASE; HEPATIC STEATOSIS; OXIDATIVE STRESS; VISCERAL FAT; CHILDREN; PATHOGENESIS; OBESITY;
D O I
10.5114/ceh.2021.104441
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Non-alcoholic fatty liver disease (NAFLD) has become the most common liver pathology worldwide due to the rising prevalence of obesity. This term includes changes from simple steatosis to steatohepatitis and fibrosis. It was previously thought to be a hepatic manifestation of metabolic syndrome, but recent literature describes this relation as much more complex and bi-directional. Development of NAFLD is associated with other metabolic syndrome components but it can also exacerbate insulin resistance and increase cardiovascular risk. Recently a lot of attention is brought to the role of lipids and lipotoxicity in pathogenesis and progression of non-alcoholic fatty disease. It seems that some lipid classes can be protective against liver injury while others are harmful in excessive amounts. This study presents an overview of the main lipids involved in the pathogenesis of non-alcoholic fatty liver disease and summarizes their association with lipotoxicity, insulin resistance, oxidative stress and other processes responsible for its progression.
引用
收藏
页码:1 / 6
页数:6
相关论文
共 75 条
[1]   Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation [J].
Alberti, KGMM ;
Zimmet, P ;
Shaw, J .
DIABETIC MEDICINE, 2006, 23 (05) :469-480
[2]   Triglyceride Metabolism in the Liver [J].
Alves-Bezerra, Michele ;
Cohen, David E. .
COMPREHENSIVE PHYSIOLOGY, 2018, 8 (01) :1-22
[3]   Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatiosis in patients with non-alcoholic fatty liver disease [J].
Araya, J ;
Rodrigo, R ;
Videla, LA ;
Thielemann, L ;
Orellana, M ;
Pettinelli, P ;
Poniachik, J .
CLINICAL SCIENCE, 2004, 106 (06) :635-643
[4]   The interaction of hepatic lipid and glucose metabolism in liver diseases [J].
Bechmann, Lars P. ;
Hannivoort, Rebekka A. ;
Gerken, Guido ;
Hotamisligil, Goekhan S. ;
Trauner, Michael ;
Canbay, Ali .
JOURNAL OF HEPATOLOGY, 2012, 56 (04) :952-964
[5]   The Role of n-3 Long Chain Polyunsaturated Fatty Acids in Cardiovascular Disease Prevention, and Interactions with Statins [J].
Bird, Julia K. ;
Calder, Philip C. ;
Eggersdorfer, Manfred .
NUTRIENTS, 2018, 10 (06)
[6]   The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD) [J].
Buzzetti, Elena ;
Pinzani, Massimo ;
Tsochatzis, Emmanuel A. .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2016, 65 (08) :1038-1048
[7]  
Calcaterra V, 2017, J PEDIATR ENDOCR MET, V30, P1257, DOI [10.1515/jpem-017-0239, 10.1515/jpem-2017-0239]
[8]   n-3 fatty acids and the metabolic syndrome [J].
Carpentier, Yvon A. ;
Portois, Laurence ;
Malaisse, Willy J. .
AMERICAN JOURNAL OF CLINICAL NUTRITION, 2006, 83 (06) :1499S-1504S
[9]  
Chalasani NP, 2017, HEPATOLOGY, V66, p303A
[10]   Oleic acid protects saturated fatty acid mediated lipotoxicity in hepatocytes and rat of non-alcoholic steatohepatitis [J].
Chen, Xuanming ;
Li, Linzhao ;
Liu, Xiaohong ;
Luo, Ruixi ;
Liao, Guangneng ;
Li, Lan ;
Liu, Jingping ;
Cheng, Jingqiu ;
Lu, Yanrong ;
Chen, Younan .
LIFE SCIENCES, 2018, 203 :291-304